RESUMEN
This study examines the relationship of time to cochlear implant patient performance and the effect of device design on patient performance over time. Data were collected for patients who were implanted with Nucleus 22, Smith & Nephew Richards Ineraid, or 3M/Vienna cochlear implants as part of the Veterans Administration study on cochlear implants. Patients were administered a comprehensive audiological test battery prior to implantation, at stimulation, and 3 months, 1 year, and 2 years poststimulation. Results show that patient performance improved over the course of the study, with performance levels with each multichannel implant being similar at the study end point. The Nucleus device produced maximum performance sooner than the Ineraid device did, and performance of the single-channel 3M was consistently below that of the multichannel devices.